On December 16, the China Bioproducts Development Laboratory of Thermo Fisher Scientific, a world leader in scientific services, was officially opened. The new laboratory is located at Thermo Fisher Scientific China Innovation Center in Shanghai, and is committed to helping Chinese users improve innovation and expand production capacity.
With a total investment of more than USD 2 million, equipped with a cell culture laboratory with a total area of about 50 square meters and an analysis laboratory of nearly 70 square meters, Thermo Fisher is another milestone in the field of biopharmaceuticals.
Relying on its global resources and leading technology and service capabilities in the biopharmaceutical field, Thermo Fisher China Bioproduct Development Lab aims to provide customers in the Chinese bioproduct industry with first-class technology, services and management to help them extend the culture medium and process Production and innovation capabilities and help them meet and meet increasingly stringent production and approval standards.
Specifically, the laboratory will help customers improve the success rate of research and development, accelerate their research and development, and provide a series of services such as formulation research and development, small-scale trial production and large-scale mass production and supply. The R & D team based in China and familiar with the market will provide customers with powerful help and support in all aspects of new drug research and development, clinical trials, drug production, and market entry efficiency according to the actual needs of Chinese customers.
Gianluca Pettiti, President of Thermo Fisher China, said: "We are very proud to establish a bioproduct development laboratory in China to participate in the development of biopharmaceuticals in China. Thermo Fisher has been focusing on China's local R & D capabilities and practice Our firm determination to take root in China and serve China. This increase in investment in our innovation center in China and the establishment of a new China biological product development laboratory is the best expression of our commitment to local customers and the Chinese market. "
Cory Stevenson, Global President of Thermo Fisher Scientific, said: "Biopharmaceuticals are still a rapidly growing industry worldwide. As the second largest market after the United States, we attach great importance to market changes and markets in China. Demand, which is also one of the main reasons we set up our first laboratory in the field of biopharmaceuticals in China. We look forward to helping local innovation in China's biopharmaceuticals and helping companies to solve the challenges faced by the escalating needs of the Chinese pharmaceutical industry. Problems encountered. The laboratory is an extension of Thermo Fisher Scientific's Gibco Biological Products Services team in China and will work closely with the Thermo Fisher Cell Culture Technology Center on Grand Island, USA. "
Dr. Zhisheng Chen, CEO of Shanghai Wuming Biotechnology Co., Ltd. said, "Thermo Fisher has always been our loyal partner. We are happy to see Thermo Fisher bring this laboratory, which represents a benchmark in the field of biopharmaceutical industry, to China to help Chinese pharmaceutical companies. Reducing the span of international standards of technology and industry standards. Helping Chinese companies strengthen their ability to develop innovative drugs and ultimately provide patients with high-quality, low-cost drugs. "
The Thermo Scientific China Bioproducts Development Lab will be part of the Thermo Scientific China Innovation Center, indicating that Thermo Scientific continues to expand its local R & D team and strengthen local innovation capabilities.
At present, the laboratory is equipped with Thermo Scientific's world-leading instruments, which can provide strong technical support for innovative research and development in the biopharmaceutical field, including such as UHPLC system and world-class high-throughput culture medium and process development facilities, such as Ambr15 Automatic cell culture system and BioHT biochemical analyzer.
In addition, the laboratory will integrate analytical equipment such as Thermo Scientific's second-generation sequencing AB3500 to enhance laboratory research capabilities. Thermo Fisher upgraded its China Technology Center, which was established in 2010, to a China Innovation Center in 2013, aiming to increase Thermo Fisher's local R & D capabilities in China to help Chinese customers make the world healthier, cleaner and safer.
Thermo Fisher Scientific China
Thermo Fisher Scientific has entered China for more than 35 years. Its headquarters in China is in Shanghai, and branches have been established in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi'an, Nanjing, Wuhan, Kunming and other places. The number of employees About 3800 people. Our products mainly include analytical instruments, laboratory equipment, reagents, consumables and software, etc., providing comprehensive laboratory solutions to serve customers in various industries. In order to meet the needs of the Chinese market, there are currently 10 factories operating in Shanghai, Beijing, Guangzhou and Suzhou.
We have set up a total of 5 application development centers across the country, bringing world-class cutting-edge technologies and products to domestic customers, and providing multiple services such as application development and training; the China Innovation Center in Shanghai combines the needs of the domestic market and foreign advanced Technology, research and development of technologies and products suitable for China; we have maintenance service outlets throughout the country and a specially established Chinese technical training team, with more than 2,000 professionals in the country directly providing services to customers. We are committed to helping our customers make the world healthier, cleaner and safer.